{
  "id": 14487370,
  "title": "Pharma: Investoren wollten früheres Curevac-Werk kaufen – Biontech macht es lieber dicht",
  "url": "https://urgent.news/2026/10/14/pharma-investoren-wollten-fruheres-curevac-werk-kaufen-biontech-macht-14487370",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-14T15:00:12.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/pharma-trotz-angebot-biontech-schliesst-das-fruehere-curevac-werk/100260007.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Interne Dokumente legen nahe: Der Impfstoff-Hersteller verhandelte monatelang über den Verkauf seiner mRNA-Labore in Tübingen – und brach dann ab. Die Interessenten sind offenbar entsetzt.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Handelsblatt",
        "title": "Pharma: Investoren wollten früheres Curevac-Werk kaufen – Biontech macht es lieber dicht",
        "url": "https://urgent.news/2026/10/14/pharma-investoren-wollten-fruheres-curevac-werk-kaufen-biontech-macht",
        "published": "2026-10-14T15:00:12.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}